Clinical Trial Update: Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial (ITAALD) investigating integrated therapies for alcohol use in alcohol-associated hepatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol-associated Hepatitis

Snippet

Sponsor: Samer Gawrieh | Conditions: Alcohol-associated Hepatitis | Phase 2 | Status: RECRUITING